Life Sciences

When Matt Zicaro joined forces with Michael O’Brien of Galaxy Development, they launched a new development firm – Galaxy Life Sciences – committed to building out the bioscience industry in Central Massachusetts.

Holliston biotechnology company Biostage, Inc. announced last week it had cut its third quarter losses through reductions in research and development and administrative expenses.

Marlborough medical device manufacturer Boston Scientific has entered into an agreement to purchase a Minnesota mobile cardiac health company for up to $1.2 billion, although due to stock ownership the final price is likely to be closer to $275 million.

An insulin management system made by Acton medical device company Insulet is now available in Canada, the company announced on Monday.

Marlborough’s Cytiva, the rebranded GE Healthcare Life Sciences, has been named as a founding member of a forthcoming 40,000 square-foot manufacturing and innovation center at the The Arsenal on the Charles in Watertown.

Marlborough medical device company CardioFocus announced on Monday that it has expanded sales to Spain and Portugal.

Boston Scientific reported an $830 million decline in net sales for 2020 compared to the previous year.

Marlborough medical device manufacturer Boston Scientific Corp. has announced a limited market release of a new pain-relief system that uses electrical impulses in the spine to block pain signals.

Hologic is continuing its acquisition spree with an agreement to purchase San Diego cancer test firm Biotheranostics for $230 million, the Marlborough company announced late on Monday.

Diagnostic company Oxford Immunotec, which has U.S. headquarters in Marlborough, will be acquired by Waltham-based PerkinElmer for $591 million, the companies announced Thursday morning.